Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2024 08:05 ET | Source: BlueWillow Biologics

BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe

ANN ARBOR, Mich., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of intranasal vaccines, today announced that the company will...
September 05, 2024 04:05 ET | Source: Research and Markets

Vaccine Adjuvants Strategic Research Report 2024

Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Vaccine...
August 28, 2024 04:27 ET | Source: Research and Markets

H1N1 Vaccines Strategic Research Report 2024: Increasing Influenza Outbreaks and Viral Mutations Accelerates Demand - Global Market Forecast to 2030

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for H1N1 Vaccines is...
April 10, 2024 04:05 ET | Source: Research and Markets

Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others

Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The...
February 21, 2024 11:34 ET | Source: Research and Markets

Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements

Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
January 24, 2024 14:18 ET | Source: Research and Markets

Vaccine Adjuvants Industry Forecast to 2034: A $7.36 Billion Market Opportunity, Dominated by Merck & Co, Thermo Fisher Scientific, and Pacific GeneTech

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global vaccine...
December 12, 2023 04:53 ET | Source: Research and Markets

FLUAD QUADRIVALENT Drug Insight and Market Forecasts, 2019-2032: Focus on 6MM - United States, Germany, France, Italy, Spain and United Kingdom

Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
December 01, 2023 10:30 ET | Source: Transparency Market Research

Adjuvants Market Size to be Worth USD 7.9 billion by 2031, at a CAGR of 6.7%| Transparency Market Research, Inc.

Wilmington, Delaware, United States, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global adjuvants market is estimated to flourish at a CAGR of 6.7% from 2022 to 2031....
December 01, 2023 06:18 ET | Source: Research and Markets

mRNA Platform Market Research Report 2023 - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The "mRNA Platform Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
November 06, 2023 07:48 ET | Source: Research and Markets

Global Therapeutic Vaccines Market Analysis 2023-2028: Regulatory Complexities Slow Entry Into the ~$12 Billion-Projected Industry

Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Therapeutic Vaccines Market (2023-2028) by Product, Disease Indication, Technology, End User, and Geography, Competitive Analysis, Impact of...